Kexing Biopharm Co., Ltd. Class A news

Investor announcements, newest first.

Close
Company news
Kexing Biopharm Co., Ltd. Class A
Sep 24, 2025
Sep 24
Sep 24, 2025
Original

Announcement on Voluntary Disclosure of Inclusion of Human Interferon α1b Inhalation Solution Being Included in the List of Drugs Granted Breakthrough Therapy Designation

Announcement on Voluntary Disclosure of Inclusion of Human Interferon α1b Inhalation Solution Being Included in the List of Drugs Granted Breakthrough Therapy Designation

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment